Status:

COMPLETED

Sentinel Node and Endometrial Cancer

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Endometrial Neoplasms

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to investigate the relevance of sentinel node in endometrial cancer. Sentinel node is thought to reflect the status of lymph node. Only 10 to 20% of women with endometrial...

Detailed Description

To investigate the relevance of sentinel node in endometrial cancer. Sentinel node is though to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit lymph node met...

Eligibility Criteria

Inclusion

  • patient over 18 years old with a surgery planned for endometrial cancer
  • endometrial cancer proved by biopsy
  • early stage of endometrial cancer (FIGO stage 1-2)
  • without contraindication to surgery
  • inform consent signed
  • affiliated to general health system

Exclusion

  • endometrial cancer FIGO stages 3-4
  • previous history of surgery modifying lymphatic drainage (conization myomectomy)
  • pregnant women or breast feeding

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

133 Patients enrolled

Trial Details

Trial ID

NCT00987051

Start Date

April 1 2007

End Date

October 1 2011

Last Update

December 11 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tenon Hospital

Paris, France, 75020